Kuhn & Co Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
2,779
+11
+0.4% +$3.77K 0.58% 48
2026
Q1
$974K Hold
2,768
0.63% 48
2025
Q4
$906K Buy
2,768
+18
+0.7% +$5.71K 0.6% 50
2025
Q3
$776K Sell
2,750
-18
-0.7% -$5.22K 0.61% 50
2025
Q2
$773K Hold
2,768
0.58% 58
2025
Q1
$862K Hold
2,768
0.73% 40
2024
Q4
$721K Hold
2,768
0.61% 52
2024
Q3
$892K Hold
2,768
0.76% 39
2024
Q2
$865K Hold
2,768
0.78% 40
2024
Q1
$787K Hold
2,768
0.74% 42
2023
Q4
$797K Buy
+2,768
New +$754K 0.82% 43

Other funds holding AMGN

Kuhn & Co Investment Counsel's AMGN Position: Q2 2026 in Review

Kuhn & Co Investment Counsel increased its Amgen (AMGN) stake by 0.4% in Q2 2026, buying an estimated $3.77K and bringing the position to 2,779 shares worth $1.01M. The position accounts for 0.58% of the portfolio, ranked #48.

Kuhn & Co Investment Counsel first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kuhn & Co Investment Counsel held 2,779 shares of Amgen worth $1.01M as of Q2 2026.
  • Kuhn & Co Investment Counsel bought 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.58% of Kuhn & Co Investment Counsel's portfolio in Q2 2026, its #48 holding.
  • Kuhn & Co Investment Counsel first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.